SOLIGENIX, INC. Stockholders' Equity, Other Shares
SOLIGENIX, INC. (SNGX) reported Stockholders' Equity, Other Shares of 0 shares for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-27.
Discontinued › Shareholders' Equity
us-gaap:StockholdersEquityOtherShares · last filed 2012-03-27
- SOLIGENIX, INC. stockholders' equity, other shares for the quarter ending 2011-12-31 was 0.00 shares.
- SOLIGENIX, INC. stockholders' equity, other shares for fiscal 2011 was 0.00 shares.
| Period end | Stockholders' Equity, Other Shares 3 month | Stockholders' Equity, Other Shares 9 month | Stockholders' Equity, Other Shares 12 month |
|---|---|---|---|
| 2011-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | 0.00 shares 10-K · filed 2012-03-27 | |
| 2011-09-30 | 0.00 shares 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |